CADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of small molecule drugs for the treatment of central nervous system disorders. Its pipeline consists of four product candidates including pimavanserin, which is in Phase-III development as a treatment for Parkinson's disease psychosis.
This stock was on a major tear today as it made a move into new territory today. This stock has been on a tear since earlier this week, and just keeps going higher and higher. There is one thing i want you to pay attention to - The 50 day moving average. The 50 day moving average is currently around $1.57. I will show you the chart below, and you can draw your own conclusion. However, you have to put this on your watchlist right now.